Osaic Holdings’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
Osaic Holdings's PVLA Position: Q3 2026 in Review
Osaic Holdings increased its Palvella Therapeutics (PVLA) stake by 41% in Q3 2026, buying an estimated $5.49K and bringing the position to 128 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6276.
Osaic Holdings first reported a position in PVLA in Q1 2020 and has held it in 23 quarters since. 199 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- Osaic Holdings held 128 shares of Palvella Therapeutics worth $17.7K as of Q3 2026.
- Osaic Holdings bought 37 Palvella Therapeutics shares in Q3 2026, an estimated $5.49K.
- Palvella Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6276 holding.
- Osaic Holdings first reported a position in Palvella Therapeutics in Q1 2020 and has held it in 23 quarters since.
- 199 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.